IRIS
SCALA, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.560
AS - Asia 1.504
EU - Europa 621
SA - Sud America 218
Continente sconosciuto - Info sul continente non disponibili 75
AF - Africa 20
OC - Oceania 2
Totale 5.000
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.460
SG - Singapore 734
CN - Cina 418
IT - Italia 270
BR - Brasile 166
IN - India 128
VN - Vietnam 119
SE - Svezia 101
DE - Germania 86
GB - Regno Unito 69
CA - Canada 68
FI - Finlandia 26
HK - Hong Kong 26
MX - Messico 20
AR - Argentina 18
BD - Bangladesh 15
UA - Ucraina 11
ZA - Sudafrica 11
EC - Ecuador 9
ID - Indonesia 9
NL - Olanda 8
VE - Venezuela 8
CL - Cile 7
FR - Francia 7
JP - Giappone 7
ES - Italia 6
IQ - Iraq 6
KR - Corea 6
RO - Romania 6
RU - Federazione Russa 6
AT - Austria 4
PL - Polonia 4
TR - Turchia 4
UZ - Uzbekistan 4
EU - Europa 3
JM - Giamaica 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AU - Australia 2
BY - Bielorussia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EE - Estonia 2
IE - Irlanda 2
IR - Iran 2
KE - Kenya 2
LT - Lituania 2
MN - Mongolia 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PK - Pakistan 2
SA - Arabia Saudita 2
TN - Tunisia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
OM - Oman 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.931
Salva come PNG Salva come JPEG
Città #
San Jose 400
Chandler 323
Singapore 279
Dallas 208
Ashburn 193
Santa Clara 113
Milan 99
Bengaluru 97
Hefei 97
Lawrence 96
Princeton 96
Council Bluffs 84
Munich 80
Beijing 61
London 52
Chicago 51
Ottawa 51
Wilmington 50
Ho Chi Minh City 47
Des Moines 39
Catanzaro 33
Los Angeles 29
Hong Kong 26
Shanghai 25
Turku 24
São Paulo 19
Hanoi 17
Boardman 16
Guangzhou 16
Napoli 16
New York 14
Seattle 11
Brooklyn 9
San Francisco 9
Haiphong 8
Mexico City 8
Montreal 8
Redmond 8
Rio de Janeiro 8
Marano 7
Mumbai 7
Naples 7
Pune 7
Rome 7
Boston 6
Da Nang 6
Seoul 6
Shenzhen 6
Tokyo 6
Manchester 5
Stockholm 5
Xi'an 5
Augusta 4
Buffalo 4
Cape Town 4
Columbus 4
Foggia 4
Jiaxing 4
Latina 4
Luni 4
Norwalk 4
Orem 4
Timisoara 4
Warsaw 4
Amsterdam 3
Ann Arbor 3
Asunción 3
Atlanta 3
Bangkok 3
Biên Hòa 3
Campinas 3
Caracas 3
Chieti 3
Derby 3
Dhaka 3
Ferrara 3
Guayaquil 3
Johannesburg 3
Las Vegas 3
Ninh Bình 3
Niterói 3
Oklahoma City 3
Phoenix 3
Reggio Calabria 3
Santa Maria 3
The Dalles 3
Vienna 3
Ankara 2
Arequipa 2
Bandung 2
Beaver Falls 2
Benito Juarez 2
Betim 2
Cabo Frio 2
Cagliari 2
Charlotte 2
Clearwater 2
Cleveland 2
Cosenza 2
Curitiba 2
Totale 3.043
Salva come PNG Salva come JPEG
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 149
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 103
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ. 98
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 90
B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy 89
Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43 88
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 84
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 84
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 82
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 82
Human immunodeficiency virus-1 Tat activates NF-kappaB via physical interaction with IkappaB-alpha and p65 76
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 76
Cancer-associated CD43 glycoforms as target of immunotherapy 75
Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein 73
Computational analysis and in vivo validation of a microRNA encoded by the IBTK gene, a regulator of B-lymphocytes differentiation and survival 72
Cancer-associated CD43 glycoforms as target of immunotherapy 72
IkappaB-alpha Represses the Transcriptional Activity of the HIV-1 Tat Transactivator by Promoting Its Nuclear Export 71
Inhibition of HIV-1 replication in primary human monocytes by the IkappaB-alfaS32/36A repressor of NF-kappaB 70
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 68
The aftermath of the Merck's HIV vaccine trial 67
Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein 67
AUTOCRINE GROWTH-FUNCTION OF HUMAN INTERLEUKIN-1 MOLECULES 64
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 63
A new strategy for label-free detection of lymphoma cancer cells 62
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 61
Diminished active T rosette levels and increased spontaneous B lymphocyte blastogenesis in hepatitis B virus positive chronic active hepatitis 61
High attenuation and immunogenicity of a simian immunodeficiency virus expressing a proteolysis-resistant inhibitor of NF-kappa B 60
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 60
Spontaneous and mutagen-mediated amplification of a neo gene integrated at different genomic sites in Rat 2 fibroblasts 59
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 57
An NF-κB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-κB-activating stimuli 57
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 57
High efficiency of site-directed mutagenesis mediated by a single PCR product 56
Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors 56
Partial purification and MALDI-TOF MS analysis of UN1, a tumor antigen membrane glycoprotein 56
SUBSETS OF HUMAN LARGE GRANULAR LYMPHOCYTES (LGL) EXHIBIT ACCESSORY CELL FUNCTIONS 55
Epstein-Barr Virus Nuclear Antigen 2 transactivates the Long Terminal Repeat of Human Immunodeficiency Virus Type 1 53
Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line 53
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 52
Regulation of the HIV Promoter/Enhancer 51
Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context 51
Ultraviolet Mutagenesis 51
Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle 49
Antigen presentation by human monocytes: evidence for stimulant processing and requirement for interleukin 1 49
HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enancer-binding protein beta (NF-IL6) transcription factors 48
DECREASED INTERLEUKIN-1 PRODUCTION IN APLASTIC-ANEMIA 48
Structural and functional insights into IκB-α/HIV-1 Tat interaction. 48
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 48
Regulation of NF-kappa B through the nuclear processing of p105 (NF-kappa B1) in Epstein-Barr virus-immortalized B cell lines 47
Multimodal Imaging for a Theranostic Approach in a Murine Model of B-cell Lymphoma with Engineered Nanoparticles 47
MIND THE MOUSE - A CONSENSUS VIEW ON THE USE OF IMMUNODEFICIENT MICE IN IMMUNOLOGY AND ONCOLOGY 46
Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line 45
HETEROGENEITY IN THE MITOGENIC RESPONSE OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS TO A PAN-T MONOCLONAL-ANTIBODY 45
Peptide-guided targeting of GPR55 for anti-cancer therapy. 45
SEQUENTIAL INDUCTION OF C-MYC AND C-FOS MESSENGER-RNA TRANSCRIPTS DURING OKT3-INDUCED ACTIVATION OF T-CELLS 44
LYMPHOKINE ABNORMALITIES IN APLASTIC-ANEMIA - IMPLICATIONS FOR THE MECHANISM OF ACTION OF ANTITHYMOCYTE GLOBULIN 44
A NF-KAPPA-B-BINDING SITE IN TAR ENHANCES THE HIV-1 GENE-EXPRESSION IN RESPONSE TO NF-KAPPA-B ACTIVATING STIMULI 44
Regulation of HIV-long terminal repeats by interactionof C/EBP(NF-IL6) and NF-kB/rel transcription factors 43
EFFECT OF INTERLEUKIN-1-BETA ON TRANSDUCING MECHANISMS IN 235-1 CLONAL PITUITARY-CELLS .2. MODULATION OF CALCIUM FLUXES 43
INHIBITION BY ANTI-HLA CLASS-II MONOCLONAL-ANTIBODIES OF MONOCYTE-DEPENDENT T-CELL PROLIFERATION INDUCED BY MONOCLONAL-ANTIBODY OKT3 43
MUTAGENS ENHANCE THE HIV-1, INTERLEUKIN-1 (IL-1), AND INTERLEUKIN-6 (IL-6) EXPRESSION THROUGH TRANSCRIPTIONAL OR POSTTRANSCRIPTIONAL MECHANISMS 43
EFFECT OF INTERLEUKIN-1-BETA ON TRANSDUCING MECHANISMS IN 235-1 CLONAL PITUITARY-CELLS .1. MODULATION OF ADENYLATE-CYCLASE ACTIVITY 41
HUMAN INTERLEUKIN-1 (IL1) STIMULATES THE GROWTH OF ROHA-9, AN EBV-TRANSFORMED HUMAN B-CELL LINE 41
Induction of tumorigenicity and plasmacytoid differentiation in EBV-B cells by expression of exogenous interleukin-6 or IL-6 receptor genes. 41
Identification of a Btk-BAG3 complex induced by oxidative stress 41
TNF-alpha-induced secretion of C-C chemokines modulates C-C chemokine receptor 5 expression on peripheral blood lymphocytes 41
HEMODIALYSIS RELATED INDUCTION OF INTERLEUKIN-6 PRODUCTION BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS 40
EFFECTS OF RECOMBINANT INTERFERON-GAMMA ON HLA-DR ANTIGEN SHEDDING BY HUMAN PERIPHERAL-BLOOD ADHERENT MONONUCLEAR-CELLS 39
Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk 39
Perspectives for a protective HIV-1 vaccine 38
Site-directed mutagenesis mediated by a single polymerase chain reaction product 37
The Human Immunodeficiency Virus Type 1 Long Terminal Repeat is activated by monofunctional and bifunctional DNA alkylating agents in human lymphocytes 37
INTERLEUKIN-INDUCED TUMOR IMMUNOGENICITY 36
Identification and functional characterization of antigenic mimotopes of surface immunoglobulin from transformed B cells 36
Impaired generation of bone marrow B lymphocytes in mice deficient of C/EBPbeta 36
THE HIV-1 TAT PROTEIN TRANSACTIVATES THE INTERLEUKIN-6 GENE 35
PRODUCTION OF INTERLEUKIN-1 ACTIVITY BY NORMAL HUMAN PERIPHERAL-BLOOD LYMPHOCYTE-B 35
FUNCTIONAL INTERACTIONS OF NF-KAPPA-B FACTORS WITH NF-IL6-C/EBP TRANSCRIPTION FACTORS IN THE REGULATION OF HIV-1 LTR 35
IMMUNOSUPPRESSIVE ACTIVITY OF BOVINE SEMINAL RNASE ON T-CELL PROLIFERATION 34
HUMAN INTERLEUKIN-1 (IL-1) IS THE AUTOSTIMULATORY GROWTH-FACTOR FOR ROHA-9, AN EBV-TRANSFORMED HUMAN B-CELL LINE 33
REARRANGEMENT LEADING TO THE EXPRESSION OF A PROMOTERLESS NEO GENE SPONTANEOUSLY OR FOLLOWING MUTAGENIC TREATMENTS IN STABLY TRANSFORMED RAT-2 FIBROBLASTS 33
Human large granular lymphocytes are potent producers of interleukin-1 32
Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappa B (I kappa B-alpha S32/36A) and the implications for vaccine development 30
The expression of the Interleukin-6 gene is induced by the human immunodeficiency virus Tat Protein 29
INTERLEUKIN-1-BETA MODULATION OF PROLACTIN SECRETION FROM RAT ANTERIOR-PITUITARY-CELLS - INVOLVEMENT OF ADENYLATE-CYCLASE ACTIVITY AND CALCIUM MOBILIZATION 29
INTERLEUKIN-6 (IL6) INDUCES PLASMACYTOID DIFFERENTIATION OF EBV-B CELLS TRANSFECTED WITH AN IL6 RECEPTOR GENE 28
Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures. 27
EXPRESSION OF INTERLEUKINS IN L-CELLS TRANSFECTED WITH HUMAN DNA 27
Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes 27
THE EXPRESSION OF THE INTERLEUKINS GENE IS INDUCED BY THE HUMAN IMMUNODEFICIENCY VIRUS-1 TAT PROTEIN 27
DNA-DAMAGING AGENTS INCREASE THE STABILITY OF INTERLEUKIN-1-ALPHA, INTERLEUKIN-1-BETA, AND INTERLEUKIN-6 TRANSCRIPTS AND THE PRODUCTION OF THE RELATIVE PROTEINS 26
Peptide-guided targeting of GPR55 for anti-cancer therapy 26
PRODUCTION OF MULTIPLE CYTOKINES BY CLONES OF HUMAN LARGE GRANULAR LYMPHOCYTES 25
Predictive value of Epstein-Bar virus genome copy number and BZLF1 expression in blood lyphocytes of transplant recipients at risk for lymphoproliferative disease 24
Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity. 24
Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1 positive sera 22
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 22
Shc mediates IL-6 signaling by interacting with gp130 and Jaj2 kinase 21
null 6
Totale 5.000
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.657
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022320 0 2 3 78 24 5 10 99 14 38 44 3
2022/2023865 192 24 34 62 103 91 3 67 170 59 46 14
2023/2024305 66 41 27 22 25 77 2 7 1 4 11 22
2024/20251.119 170 66 96 37 88 127 19 21 160 35 104 196
2025/20262.083 112 223 283 297 228 100 251 123 245 139 57 25
2026/2027111 28 83 0 0 0 0 0 0 0 0 0 0
Totale 5.000